top of page

LATEST NEWS

N-LIfT shows potent cancer killing across multiple solid tumour types

LIfT BioSciences announces its N-LIfT cell therapy shows tumour destruction across five different solid tumour types in PDX tumouroid...

Sep 13, 2022

N-LIfT shows potent cancer killing across multiple solid tumour types

N-LIfT shows potent cancer killing across multiple solid tumour types

N-LIfT cell therapy shows complete and superior cell killing in solid tumour organoid

London, 6th March 2022 – LIfT BioSciences,a biotech bringing to market a first-in-class allogeneic innate cell therapy, today announces...

Mar 6, 2022

N-LIfT cell therapy shows complete and superior cell killing in solid tumour organoid

N-LIfT cell therapy shows complete and superior cell killing in solid tumour organoid

LIfT BioSciences secures its largest financing to date with a further £5m

London, 21st January 2022 – Biotech LIfT BioSciences today announced its largest financing round to date with a further £5m investment...

Jan 21, 2022

LIfT BioSciences secures its largest financing to date with a further £5m

LIfT BioSciences secures its largest financing to date with a further £5m

bottom of page